Identification of commonly dysregulated genes in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation

@article{Xiao2015IdentificationOC,
  title={Identification of commonly dysregulated genes in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation},
  author={W. Xiao and X. Qu and X. Li and Y. Sun and H. Zhao and S. Wang and X. Zhou},
  journal={Cancer Gene Therapy},
  year={2015},
  volume={22},
  pages={278-284}
}
The progression of colorectal cancer (CRC) is a multistep process and metastatic CRC is always incurable; consequently, CRC is the leading cause of cancer-related deaths. There is therefore an urgent need for identifying useful biomarkers with enough sensitivity and specificity to detect this disease at early stages, which will significantly reduce the mortality for this malignancy. In this study, we performed an integrating analysis of different RNA-Seq data sets to find new candidate… Expand
Identification of the Key Genes and Pathways in Esophageal Carcinoma
TLDR
The significantly DEGs including CDK4, CCT3, THSD4, and SIM2 may play key roles in tumorigenesis and development of EC involved in cell cycle and Endocytosis, which is a frequently common malignancy of gastrointestinal cancer in the world. Expand
Identification of differentially expressed genes and their upstream regulators in colorectal cancer
TLDR
These five DEGs may have roles in CRC regulated by their five upstream TFs, which may make a contribution in uncovering the mechanism and providing new strategy of diagnosis and therapies for CRC. Expand
A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
TLDR
Identifying the five-lncRNA signature may provide insight into personalized prognosis prediction and new therapies for PDAC patients and showed that a number of cancer-related and drug response pathways were enriched in high risk groups. Expand
Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction
TLDR
How each “omics” technology has individually contributed to cancer research is reviewed, technological and computational advances that have contributed to the realization of onco-proteogenomics are discussed, and current and future translational applications are summarized. Expand
Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis
TLDR
It was demonstrated that ADAMTS6 gene could be used as a potential molecular marker for GC prognosis, and it was confirmed by immunohistochemistry and qRT-PCR that ADamTS6 is highly expressed in GC, which may be related to the prognosis of GC patients. Expand
Prognostic Values for the mRNA Expression of the ADAMTS Family of Genes in Gastric Cancer
TLDR
According to the RNA-seq and gene chip data, the ADAMTS family of genes was closely related to the prognosis of GC, and their high expression levels were associated with poor prognosis and survival time. Expand
Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients
TLDR
Dynein axonemal heavy chain gene mutations contribute positively to chemotherapy sensitivity in gastric cancer patients and are associated with different chemotherapy responses. Expand
Onco-proteogenomic exploration of variant peptide detection in disease models and clinical specimens
TLDR
Results provide promising evidence that the combination of the well-established sequencing technologies and the excellent capabilities of state of the art mass spectrometry instruments can effectively detect variant peptides in clinical specimens and that this approach has the potential to be optimized to harness its full potential and realize precision medicine translational applications. Expand
ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer
TLDR
Data demonstrate that ADAMTS6 inhibits tumor development by regulating the ERK pathway via binding of miR-221-3p, and its expression may be a potential prognostic biomarker for BC. Expand
The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer
  • Xiao-Li Wei, Qian-Wen Liu, +5 authors Yi-hong Ling
  • Medicine
  • Oncoimmunology
  • 2021
TLDR
PD-L1 positivity indicates a subtype of EBVaGC with ‘hot’ immune microenvironment, lower aggressiveness, better prognosis, and higher sensitivity to anti-PD-1 immunotherapy. Expand
...
1
2
...

References

SHOWING 1-10 OF 43 REFERENCES
A Network-Based Gene Expression Signature Informs Prognosis and Treatment for Colorectal Cancer Patients
TLDR
The network-based data integration method provides a convergence between biological relevance and clinical usefulness in gene signature development and not only reflects CRC biology but also informs patient prognosis and treatment response. Expand
Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer
TLDR
Evidence is offered that SOCS2 and SOCS6 levels are reduced in CRC and may serve as diagnostic biomarkers for CRC patients and the meta-analysis as well as the independent patient cohort analysis reveal a stage-independent downregulation of SOCS 2 and SOCs6. Expand
Identification of candidate epigenetic biomarkers for ovarian cancer detection.
TLDR
The data have identified, for the first time, GTF 2A1 alone, or GTF2A1 plus HAAO are excellent candidate biomarkers for detecting this disease. Expand
Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis
TLDR
This review summarizes the most investigated biomolecular pathways involved in CRC pathogenesis, their role as biomarkers for early CRC diagnosis and their possible use to stratify susceptible patients into appropriate screening or surveillance programs. Expand
A molecular signature for oncogenic BRAF in human colon cancer cells is revealed by microarray analysis.
TLDR
Novel selected genes/pathways are validated in cell lines and clinical samples bearing BRAFV600E and may serve as markers/targets for personalised diagnosis/therapy/resistance of colorectal cancer. Expand
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion
TLDR
Previously unidentified levels of genomic rearrangements in colorectal carcinoma that can lead to essential gene fusions and other oncogenic events are shown. Expand
Systems Biology Approach to Identify Gene Network Signatures for Colorectal Cancer
TLDR
This work integrated prior knowledge from gene signatures and protein interactions with gene set enrichment analysis (GSEA), and gene/protein network modeling together to identify gene network signatures from gene expression microarray data, and constructed an integrated protein–protein interaction (PPI) network. Expand
Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon.
TLDR
The authors' data showed continuous down-regulation of PLA2G2A in the sequence supporting an implication in human colon cancer, and TGF-beta2 and matrix metalloproteinase 23B were up-regulated in carcinoma but not in adenoma, supporting the pathobiological roles in malignant transformation. Expand
Differential meta-analysis of RNA-seq data from multiple studies
BackgroundHigh-throughput sequencing is now regularly used for studies of the transcriptome (RNA-seq), particularly for comparisons among experimental conditions. For the time being, a limited numberExpand
A Comprehensive Characterization of Genome-Wide Copy Number Aberrations in Colorectal Cancer Reveals Novel Oncogenes and Patterns of Alterations
TLDR
Non-random correlation between CNAs among unlinked loci, including positive correlation between 20 q gain and 8 q gain, and 20Q gain and chromosome 18 loss, are revealed, consistent with co-selection of these CNAs. Expand
...
1
2
3
4
5
...